Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness

Journal of Infectious Diseases

Volumn 197, Issue 2, 2008, Pages 300-308

  Sanchez Merino, Victor ^a   Farrow, Melissa A ^a,b   Brewster, Frank ^a   Somasundaran, Mohan ^a   Luzuriaga, Katherine ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Center for Interdisciplinary Studies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAG PROTEIN; PROTEIN P17; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; P17 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CD8+ T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FITNESS; GENE MUTATION; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MOLECULAR CLONING; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VIRUS ISOLATION; VIRUS MUTATION; VIRUS REPLICATION; WILD TYPE; AMINO ACID SUBSTITUTION; CHEMISTRY; DISEASE TRANSMISSION; DNA SEQUENCE; GENETIC TRANSFECTION; GENETICS; HELA CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INFANT; METABOLISM; MOLECULAR GENETICS; MUTATION; PATHOGENICITY; PHYSIOLOGY; VIROLOGY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CD8-POSITIVE T-LYMPHOCYTES; DISEASE TRANSMISSION, VERTICAL; EPITOPES, T-LYMPHOCYTE; FEMALE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HELA CELLS; HIV ANTIGENS; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, DNA; TRANSFECTION; VIRUS REPLICATION;

EID: 39149111272     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/524845     Document Type: Article

References (33)

1. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994; 68:6103-10.
2. + T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999; 189:991-8.
3. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994; 68:4650-5.
4. Kuroda MJ, Schmitz JE, Charini WA, et al. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J Immunol 1999; 162:5127-33.
5. Lifson JD, Rossio JL, Arnaout R, et al. Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment. J Virol 2000; 74:2584-93.
6. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999; 283:857-60.
7. Allen TM, Altfeld M, Geer SC, et al. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol 2005; 79:13239-49.
8. Coffin JM. HIV viral dynamics. AIDS 1996; 10(3 Suppl):S75-84.
9. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002; 296:1439-43.
10. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373:123-6.
11. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373:117-22.
12. Allen TM, O'Connor DH, Jing P, et al. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 2000; 407:386-90.
13. Barouch DH, Kunstman J, Glowczwskie J, et al. Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys. J Virol 2003; 77:7367-75.
14. Borrow P, Lewicki H, Wei X, et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997; 3:205-11.
15. Goulder PJ, Phillips RE, Colbert RA, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997; 3:212-7.
16. Koenig S, Conley AJ, Brewah YA, et al. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat Med 1995; 1:330-6.
17. Phillips RE, Rowland-Jones S, Nixon DF, et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991; 354:453-9.
18. Price DA, Goulder PJ, Klenerman P, et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 1997; 94:1890-5.
19. Goulder PJ, Brander C, Tang Y, et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 2001; 412:334-8.
20. Leslie AJ, Pfafferott KJ, Chetty P, et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004; 10:282-9.
21. Milicic A, Edwards CT, Hue S, et al. Sexual transmission of single human immunodeficiency virus type 1 virions encoding highly polymorphic multisite cytotoxic T-lymphocyte escape variants. J Virol 2005; 79:13953-62.
22. Pillay T, Zhang HT, Drijfhout JW, et al. Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection. J Virol 2005; 79:12100-5.
23. Sanchez-Merino V, Nie S, Luzuriaga K. HIV-1-specific CD8+ T cell responses and viral evolution in women and infants. J Immunol 2005; 175:6976-86.
24. Altman JD, Feinberg MB. HIV escape: there and back again. Nat Med 2004; 10:229-30.
25. Fernandez CS, Stratov I, De Rose R, et al. Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J Virol 2005; 79:5721-31.
26. Friedrich TC, Dodds EJ, Yant LJ, et al. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat Med 2004; 10:275-81.
27. Vogel TU, Friedrich TC, O'Connor DH, et al. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence? J Virol 2002; 76:11623-36.
28. Martinez-Picado J, Prado JG, Fry EE, et al. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J Virol 2006; 80:3617-23.
29. Bryson YJ, Luzuriaga K, Sullivan JL, Wara DW. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med 1992; 327:1246-7.
30. Dorfman T, Mammano F, Haseltine WA, Gottlinger HG. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J Virol 1994; 68:1689-96.
31. Reid SW, McAdam S, Smith KJ, et al. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J Exp Med 1996; 184:2279-86.
32. Friedrich TC, Frye CA, Yant LJ, et al. Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response. J Virol 2004; 78:2581-5.
33. von Schwedler UK, Stray KM, Garrus JE, Sundquist WI. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol 2003; 77:5439-50.